Cardurion Pharmaceuticals is a next generation cardiovascular company focused on the discovery and development of novel therapeutics for the treatment of heart failure and other cardiovascular diseases. Led by an experienced team of CV experts and industry veterans, we are developing groundbreaking clinical programs in PDE9 and CaMKII inhibition. We take a strategic portfolio approach driven by in-house drug discovery and our office of strategy and have concluded foundational partnerships with key strategics and investors, including an up to $300 million dollar investment from Bain Capital to support current programs and pipeline growth. Cardurion Pharmaceuticals has facilities in Burlington, Massachusetts and Shonan, Japan. For more information, please visit the company’s website at http://www.cardurion.com.
Company Details
- Employees
- 77
- Founded
- -
- Address
- 78 Blanchard Road, Suite 200,japan
- Phone
- 617-996-1433
- in****@****ion.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cardurion.com
- HQ
- Burlington, Massachusetts
Cardurion Pharmaceuticals Questions
Cardurion Pharmaceuticals's helpline number is 617-996-1433
Cardurion Pharmaceuticals's website is cardurion.com
Cardurion Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/cardurion
Cardurion Pharmaceuticals has
77 employees.
View email and phone details for 77
employees at Cardurion Pharmaceuticals.
Cardurion Pharmaceuticals's industry is
Biotechnology Research
Cardurion Pharmaceuticals's top competitors are
Formation Bio,
Candid Therapeutics,
Treeline Biosciences,
Metsera,
Mirador Therapeutics,
Arsenal Biosciences, Inc.,
Scorpion Therapeutics,
Kailera Therapeutics,
Alumis,
Xaira Therapeutics.
Cardurion Pharmaceuticals's support email address is info@cardurion.com
Cardurion Pharmaceuticals's categories are Biotechnology Research
Cardurion Pharmaceuticals's founding year is 2017
